EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations

Marco Barale iD, Federica Maiorino, Alessia Pusterla, Federica Fraire, Lorenzo Sauro, Michela Presti, Noemi Sagone, Ezio Ghigo, Emanuela Arvat, Massimo Procopio

Endocrine · 15.10.2024 · 86 (3) · 1140-1147

DOI: 10.1007/s12020-024-04063-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, online erschienen am 15.10.2024. Verfasst von Marco Barale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncological Endocrinology; Department of Medical Sciences, University of Turin, Turin, Italy. marco.barale@unito.it. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Cardiovascular Diseases, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cardiometabolic disorders are non-classical complications of hypercalcemic primary hyperparathyroidism (HC-PHPT), but whether this risk connotes normocalcemic PHPT (NC-PHPT) remains to be elucidated. We investigated cardiometabolic alterations in both forms of PHPT, looking for their association with indices of disease activity.

Methods

Patients with HC-PHPT ( n = 17), NC-PHPT ( n = 17), and controls ( n = 34) matched for age, sex, and BMI were assessed for glucose, lipid, blood pressure alterations, and history of cardiovascular events to perform a case–control study at an ambulatory referral center for Bone Metabolism Diseases.

Results

NC-PHPT, in comparison to controls, showed similar glucose (mean ± SD, 88 ± 11 vs 95 ± 22 mg/dl), total cholesterol (199 ± 25 vs 207 ± 36 mg/dl), and systolic blood pressure levels (SBP, 132 ± 23 vs 132 ± 19 mmHg), together with a comparable frequency of glucose alterations (6% vs 9%), lipid disorders (41% vs 50%) and hypertension (53% vs 59%, p = NS for all comparisons). Conversely, all these abnormalities were more prevalent in HC-PHPT vs controls ( p < 0.05). When compared to NC-PHPT, HC-PHPT showed higher glucose (113 ± 31 mg/dl), total cholesterol (238 ± 43 mg/dl), and SBP levels (147 ± 15 mmHg) as well as an increased frequency of glucose (41%) and lipid alterations (77%) and a higher number of cardiovascular events (18% vs 0%, p < 0.05 for all comparisons). Among indices of PHPT activity, calcium levels displayed a significant correlation with glucose (R = 0.46) and SBP values (R = 0.60, p < 0.05).

Conclusion

NC-PHPT is not associated with cardiovascular alterations. The predominant pathogenetic role of hypercalcemia in the development of cardiometabolic disorders could account for the absence of such alterations in NC-PHPT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryCardiovascular DiseasesBlood GlucoseHumansFemaleMaleMiddle AgedCase-Control StudiesAgedBlood PressureHypercalcemiaCalciumAdultHypertension

Stichwörter der Autor:innen

Blood pressureCalciumCardiometabolicGlucoseNormocalcemic primary hyperparathyroidismParathormone

Substanzen

Blood GlucoseCalcium

Autor:innen und Institutionen

  • Division of Oncological Endocrinology; Department of Medical Sciences, University of Turin, Turin, Italy. marco.barale@unito.it.
  • Division of Endocrinology, Diabetes and Metabolism; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Division of Oncological Endocrinology; Department of Medical Sciences, University of Turin, Turin, Italy.

ORCID-Profile: Marco Barale

Zitieren

APA

Barale, M., Maiorino, F., Pusterla, A., Fraire, F., Sauro, L., Presti, M., Sagone, N., Ghigo, E., Arvat, E., & Procopio, M. (2024). Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations. Endocrine, 86(3), 1140-1147. https://doi.org/10.1007/s12020-024-04063-0

Vancouver

Barale M, Maiorino F, Pusterla A, Fraire F, Sauro L, Presti M, et al. Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations. Endocrine. 2024;86(3):1140-1147. doi:10.1007/s12020-024-04063-0

BibTeX
@article{Barale2024,
  author = {Barale, Marco and Maiorino, Federica and Pusterla, Alessia and Fraire, Federica and Sauro, Lorenzo and Presti, Michela and Sagone, Noemi and Ghigo, Ezio and Arvat, Emanuela and Procopio, Massimo},
  title = {Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations},
  journal = {Endocrine},
  year = {2024},
  volume = {86},
  number = {3},
  pages = {1140--1147},
  doi = {10.1007/s12020-024-04063-0}
}
Kostenlos starten →